ORVAC Stage 2 – Optimising Rotavirus Vaccine in Aboriginal Children: a double-blind, randomised, placebo-controlled, adaptive clinical trial of a third scheduled dose of oral rotavirus vaccine for Australian Aboriginal children.

  • Snelling, Tom (Investigator 01)
  • Middleton, Bianca (Investigator 02)
  • Danchin, Margaret (Investigator 03)
  • Jones, Mark (Investigator 04)
  • Leach, Amanda (Investigator 05)
  • Carapetis, Jonathan (Investigator 06)

Project Details

StatusActive
Effective start/end date1/01/22 → 31/12/26

Funding

  • NHMRC National Health and Medical Research Council